marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Crinetics Pharmaceuticals Gewinn / Verlust 2011-2024 | CRNX
Gewinn / Verlust Jährlich Crinetics Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
2.46 B | 1.02 B | 1.09 B | 430 M | 535 M | 300 M | - | - | - | - | - | - | - |
Anteile |
58.1 M | 52 M | 38.4 M | 30.4 M | 24.2 M | 12.1 M | - | - | - | - | - | - | - |
Kurshistorie |
42.4 | 19.7 | 28.4 | 14.1 | 25.1 | 30 | - | - | - | - | - | - | - |
Nettogewinn |
-215 M | -164 M | -108 M | -73.8 M | -50.4 M | -27.1 M | -9.16 M | -6.02 M | - | - | - | - | - |
Umsatz |
4.01 M | 4.74 M | 1.08 M | 71 K | 1.19 M | 2.43 M | 2.04 M | 589 K | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-223 M | -168 M | -108 M | -75 M | -53.8 M | -28.7 M | -9.13 M | -6.04 M | - | - | - | - | - |
Zinsaufwendungen |
- | - | - | - | - | - | 8 K | 11 K | - | - | - | - | - |
EBITDA |
-222 M | -167 M | -107 M | -74 M | -52.9 M | -28.2 M | -9 M | -5.95 M | - | - | - | - | - |
Betriebsaufwand |
227 M | 173 M | 109 M | 75 M | 55 M | 31.1 M | 11.2 M | 6.63 M | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
58.1 M | 42.4 M | 24.5 M | 18 M | 13.5 M | 6.66 M | 1.94 M | 1.53 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Crinetics Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
80.1 M | 79 M | 72.3 M | 68.2 M | 56.8 M | 54.3 M | 53.9 M | 53.9 M | 53.8 M | 52.5 M | 47.7 M | 47.6 M | 38.3 M | 37.1 M | 33 M | 33 M | 32.9 M | 31.4 M | 24.5 M | 24.3 M | 24.2 M | 24.2 M | 24.1 M | 24.1 K | 20 M | 2.31 M | 1.87 M | 1.55 M | 1.43 M | 1.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-76.8 M | -74.1 M | -66.9 M | - | -57.5 M | -51 M | -46 M | - | -41.9 M | -42.4 M | -34.6 M | - | -27.9 M | -26.1 M | -22.9 M | - | -18.3 M | -16.5 M | -17.4 M | -14.5 M | -14.4 M | -12.4 M | -9.02 M | -8.5 M | -7.59 M | -5.57 M | -5.46 M | -2.52 M | -2.38 M | -1.65 M | -2.61 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Einnahmen |
- | 399 K | 640 K | - | 346 K | 988 K | 2.68 M | - | 458 K | 439 K | 3.13 M | - | - | - | - | - | 71 K | 71 K | 71 K | 321 K | 505 K | 367 K | 367 K | 781 K | 548 K | 657 K | 442 K | 528 K | 640 K | 832 K | 45 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-87.8 M | -82.8 M | -73.5 M | - | -59 M | -53 M | -48 M | - | -43.5 M | -43 M | -33.8 M | - | -27.8 M | -26.1 M | -22.9 M | - | -18.5 M | -16.9 M | -17.8 M | - | -15.2 M | -13.3 M | -10 M | - | -8.07 M | -5.68 M | -5.53 M | - | -2.37 M | -1.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2 K | 3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -73.1 M | - | - | - | -47.7 M | - | -42.8 M | -42.6 M | -33.6 M | - | -27.1 M | -25.6 M | -22.7 M | - | -17.7 M | -16.4 M | -17.5 M | - | -14.6 M | -12.9 M | -9.84 M | - | -7.81 M | -5.56 M | -5.48 M | - | -2.29 M | -1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
87.8 M | 83.2 M | 74.2 M | - | 59.3 M | 54 M | 50.7 M | - | 43.9 M | 43.5 M | 37 M | - | 27.8 M | 26.1 M | 22.9 M | - | 18.5 M | 16.9 M | 17.9 M | 15.5 M | 15.7 M | 13.3 M | 10.4 M | 10.2 M | 8.62 M | 6.34 M | 5.97 M | 3.03 M | 3.01 M | 2.48 M | 2.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
25.9 M | 24.8 M | 20.8 M | - | 15.5 M | 13.3 M | 12.2 M | - | 11.9 M | 10.5 M | 8.71 M | - | 6.23 M | 5.6 M | 5.33 M | - | 4.75 M | 4.32 M | 3.99 M | 3.39 M | 3.91 M | 3.06 M | 3.16 M | 2.56 M | 1.73 M | 1.12 M | 1.25 M | 467 K | 491 K | 392 K | 589 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung